The FDA approved Eli Lilly’s drug Kisunla to treat early-stage Alzheimer’s disease. Kisunla is only the second drug approved to treat the incurable disease. Medicare is expected to cover the $32,000 cost. NBC News’ Anne Thompson reports. NBC News Health
The FDA approved Eli Lilly’s drug Kisunla to treat early-stage Alzheimer’s disease. Kisunla is only the second drug approved to treat the incurable disease. Medicare is expected to cover the $32,000 cost. NBC News’ Anne Thompson reports.
